SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001070698-12-000058
Filing Date
2012-07-10
Accepted
2012-07-10 15:37:21
Documents
12
Period of Report
2012-05-31
Filing Date Changed
2012-07-10

Document Format Files

Seq Description Document Type Size
1 RAPTOR PHARMACEUTICAL CORP 10-Q_Q312_5-31-2012 form10q.htm 10-Q 1733207
2 CERTIFICATION OF CHRISTOPHER M. STARR, PH.D., CHIEF EXECUTIVE OFFICER ex31_1.htm EX-1.1 7752
3 CERTIFICATION OF KIM R. TSUCHIMOTO, CHIEF FINANCIAL OFFICER ex31_2.htm EX-31.2 7654
4 CERTIFICATION OF CHRISTOPHER M. STARR, PH.D AND KIM R. TSUCHIMOTO ex32_1.htm EX-32.1 8466
5 EMPLOYMENT AGREEMENT - RAPTOR EUROPE BV AND HENK DOUDE VAN TROOSTWIJK ex10_1.htm EX-10.1 81663
6 INTELLECTUAL PROPERTY PLATFORM CONTRIBUTION TRANSACTION LICENSE AGREEMENT ex10_2.htm EX-10.2 126388
  Complete submission text file 0001070698-12-000058.txt   5693187

Data Files

Seq Description Document Type Size
7 rptp-20120531_pre.xml EX-101.PRE 114917
8 rptp-20120531_lab.xml EX-101.LAB 263912
9 rptp-20120531_def.xml EX-101.DEF 19726
10 rptp-20120531_cal.xml EX-101.CAL 39679
11 rptp-20120531.xsd EX-101.SCH 20298
12 rptp-20120531.xml EX-101.INS 849034
Mailing Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949
Business Address 9 COMMERCIAL BLVD SUITE 200 NOVATO CA 94949 415-382-1390
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-25571 | Film No.: 12955926
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1